175 related articles for article (PubMed ID: 37182286)
1. Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy.
Zhang Z; Fu N; Li Q; Quan J
Biochem Biophys Res Commun; 2023 Jul; 666():115-121. PubMed ID: 37182286
[TBL] [Abstract][Full Text] [Related]
2. Uricase-Deficient Larval Zebrafish with Elevated Urate Levels Demonstrate Suppressed Acute Inflammatory Response to Monosodium Urate Crystals and Prolonged Crystal Persistence.
Linnerz T; Sung YJ; Rolland L; Astin JW; Dalbeth N; Hall CJ
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553446
[TBL] [Abstract][Full Text] [Related]
3. Difficult-to-treat gouty arthritis: a disease warranting better management.
Schlesinger N
Drugs; 2011 Jul; 71(11):1413-39. PubMed ID: 21812506
[TBL] [Abstract][Full Text] [Related]
4. Pegloticase treatment of chronic refractory gout: Update on efficacy and safety.
Schlesinger N; Lipsky PE
Semin Arthritis Rheum; 2020 Jun; 50(3S):S31-S38. PubMed ID: 32620200
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Human Proteoglycan 4 Regulates Phagocytic Activation of Monocytes and Reduces IL-1β Secretion by Urate Crystal Stimulated Gout PBMCs.
ElSayed S; Jay GD; Cabezas R; Qadri M; Schmidt TA; Elsaid KA
Front Immunol; 2021; 12():771677. PubMed ID: 34992596
[TBL] [Abstract][Full Text] [Related]
6. Doliroside A attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome.
Wei H; Hu C; Xie J; Yang C; Zhao Y; Guo Y; Mei Z; Chen L; Lan Z
Eur J Pharmacol; 2014 Oct; 740():321-8. PubMed ID: 25064339
[TBL] [Abstract][Full Text] [Related]
7. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
8. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
[TBL] [Abstract][Full Text] [Related]
9. Monosodium urate crystals with controlled shape and aspect ratio for elucidating the pathological progress of acute gout.
Chen C; Wang J; Liang Z; Li M; Fu D; Zhang L; Yang X; Guo Y; Ge D; Liu Y; Sun B
Biomater Adv; 2022 Aug; 139():213005. PubMed ID: 35882152
[TBL] [Abstract][Full Text] [Related]
10. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling.
Li X; Xu DQ; Sun DY; Zhang T; He X; Xiao DM
J Cell Biochem; 2019 Apr; 120(4):6718-6728. PubMed ID: 30592318
[TBL] [Abstract][Full Text] [Related]
11. Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout.
Ahn H; Lee G; Lee GS
Cells; 2021 Jul; 10(8):. PubMed ID: 34440688
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
[TBL] [Abstract][Full Text] [Related]
13. A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties.
Nyborg AC; Ward C; Zacco A; Chacko B; Grinberg L; Geoghegan JC; Bean R; Wendeler M; Bartnik F; O'Connor E; Gruia F; Iyer V; Feng H; Roy V; Berge M; Miner JN; Wilson DM; Zhou D; Nicholson S; Wilker C; Wu CY; Wilson S; Jermutus L; Wu H; Owen DA; Osbourn J; Coats S; Baca M
PLoS One; 2016; 11(12):e0167935. PubMed ID: 28002433
[TBL] [Abstract][Full Text] [Related]
14. Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.
Zhong CS; Zeng B; Qiu JH; Xu LH; Zhong MY; Huang YT; Xu R; Liu SY; Zha QB; Hu B; Ou-Yang DY; He XH
Acta Pharmacol Sin; 2022 May; 43(5):1324-1336. PubMed ID: 34376811
[TBL] [Abstract][Full Text] [Related]
15. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.
Qiao CY; Li Y; Shang Y; Jiang M; Liu J; Zhan ZY; Ye H; Lin YC; Jiao JY; Sun RH; Zhang ZH; Piao MH; Wu YL; Nan JX; Lian LH
Inflammopharmacology; 2020 Dec; 28(6):1481-1493. PubMed ID: 33006110
[TBL] [Abstract][Full Text] [Related]
16. Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation
Pan YG; Huang MT; Sekar P; Huang DY; Lin WW; Hsieh SL
Front Immunol; 2021; 12():638676. PubMed ID: 33746978
[TBL] [Abstract][Full Text] [Related]
17. Pegloticase for treating refractory chronic gout.
George RL; Sundy JS
Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
[TBL] [Abstract][Full Text] [Related]
18. Anti-gouty arthritis and anti-inflammatory effects of curcumin nanoparticles in monosodium urate crystals induced Balb/C mice.
Javed C; Noreen R; Niazi SG; Kiyani MM; Ul Ain Q
Inflammopharmacology; 2024 Jun; 32(3):1929-1940. PubMed ID: 38556563
[TBL] [Abstract][Full Text] [Related]
19. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
20. Melatonin Alleviates Acute Gouty Inflammation In Vivo and In Vitro.
Xiao WZ; Zhao L; Cao L; Zhu XX; Zou HJ
Curr Med Sci; 2021 Aug; 41(4):757-763. PubMed ID: 34047943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
